What is TestCard?
TestCard is an innovative at-home testing solution designed to deliver immediate results at a reduced cost. The company's core offering is a non-invasive urine test kit integrated into a postcard format, complemented by a mobile application. This application leverages a smartphone's camera, transforming it into a clinical-grade scanner for rapid analysis. The company's approach aims to democratize health diagnostics by making them more accessible and convenient for consumers.
How much funding has TestCard raised?
TestCard has raised a total of $11.7M across 2 funding rounds:
Angel/Seed
$1.7M
Unspecified
$10M
Angel/Seed (2018): $1.7M, investors not publicly disclosed
Unspecified (2022): $10M, investors not publicly disclosed
What's next for TestCard?
With the recent major strategic investment, TestCard is poised for significant expansion and further development of its unique diagnostic platform. The enterprise-level funding suggests a focus on scaling operations, enhancing the mobile application's capabilities, and potentially broadening its test offerings. This strategic backing will likely enable TestCard to solidify its market position and pursue new avenues for growth, possibly through partnerships or expanded distribution channels, further establishing its footprint in the rapidly evolving health-tech landscape.
See full TestCard company page
